Manhattan Vision Screening and Follow-Up Study

  • End date
    Sep 8, 2024
  • participants needed
  • sponsor
    Columbia University
Updated on 8 August 2021
eye exam
brimonidine tartrate ophthalmic solution


The investigators are conducting a 5-year prospective, cluster-randomized controlled trial, funded by the Centers for Disease Control (CDC), which provides vision screenings to underserved, vulnerable New York City residents living in affordable housing buildings in Harlem and Washington Heights.


This study aims to increase engagement, detection and management of glaucoma, vision impairment, cataracts, and other eye diseases in vulnerable populations living in New York City. This study considers disparities by race, ethnicity, gender, geography, and socioeconomic status using innovative approaches such as patient navigators. Individuals over the age of 40 living in New York City Housing Authority (NYCHA) Housing buildings are eligible.

Condition EYE DISORDER, Cataract, Ocular Hypertension, Glaucoma, Diabetic Retinopathy, Eye Disorders/Infections, Dry Eye Disease, Diabetic Macular Edema, Eye Disorders/Infections (Pediatric), Cataracts, Eye Disease, Vision Impairment and Blindness, ocular disease, ophthalmological disorder
Treatment Usual Care, Enhanced Intervention Using Patient Navigators
Clinical Study IdentifierNCT04271709
SponsorColumbia University
Last Modified on8 August 2021


Yes No Not Sure

Inclusion Criteria

Individuals over age 40
Living independently in NYCHA housing building
Willing to answer COVID-19 symptom questions
Willing to consent for 2 vision screening visits at baseline and 12-month follow-up

Exclusion Criteria

Self-reported terminal illness with life expectancy less than 1 year
Inability to provide informed consent due to dementia or other reasons
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note